Heme iron has many and varied roles in biology. Most commonly it binds as a prosthetic group to proteins, and it has been widely supposed and amply demonstrated that subtle variations in the protein structure around the heme, including the heme ligands, are used to control the reactivity of the metal ion. But the role of heme in biology now appears to also include a regulatory responsibility in the cell; this includes regulation of ion channel function. In this work, we show that cardiac KATP channels are regulated by heme. We identify a cytoplasmic heme-binding CXXHX16H motif on the SUR2A subunit of the channel, and mutagenesis together with quantitative and spectroscopic analyses of heme binding and single channel experiments identified Cys628 and His648 as important for heme binding. We discuss the wider implications of these findings and we use the information to present new hypotheses for mechanisms of heme-dependent regulation across other ion channels.
\body
Heme is a small organic molecule with iron in the centre and it plays a vital role in a wide range of biological systems. Heme-containing proteins form a large and biologically important group of enzymes: they are found in all living species and carry out a wide variety of functions, for example in oxygen transport (the globins), electron transfer (the cytochromes), as well as in various hemedependent catalytic processes (for example in the cytochrome P450s, nitric oxide synthases, peroxidases, dioxygenases). For many of these proteins, much structural and mechanistic information is available, and this has led to an established view that the role of heme in biology is as a prosthetic group, which means that it binds tightly to a particular protein (such as hemoglobin) thus conferring specific properties that vary according to the biological requirements. But it is now becoming clear that this represents only one part of a more complex biological picture and that heme interacts with proteins in a variety of ways and has a much wider regulatory role in the cell (1) (2) (3) (4) (5) . The mechanisms of heme regulation in biology are, at present, largely unknown.
One new regulatory role for heme is in control of ion channel function. Ion channels are central to the control of a vast range of biological processes ranging from neuronal signaling to regulation of blood pressure, and as a consequence defects in ion channel function lead to a variety of disease states. Ion channel gating (opening and closing of the pore) can be regulated by membrane potential and/or by ligand binding; furthermore, co-assembly with regulatory subunits and modulation by signaling pathways yields an additional means of control.
The molecular basis for the regulatory control in ion channels has yet to be precisely defined. The complexity of the problem is in part because the target proteins and their sites of interaction with heme are poorly characterised and are probably different in different ion channels, and because the interactions with heme are often weak and give spectroscopic signatures that are much different to those in the more well-characterised heme proteins which are often used as a benchmark.
Consequently, the development of ideas about precisely how heme regulates such complex biological events is at a preliminary stage, and the mechanisms of regulation in structurally diverse channels have yet to be unravelled.
In this paper, we have examined heme-dependent regulation in cardiac ATP-sensitive K + channels (KATP). KATP channels regulate the excitability of cardiac ventricular myocytes which is especially apparent during metabolic stress, such as, ischaemic heart disease and myocardial infarction (6) . We find clear evidence for heme-dependent modulation of cardiac KATP channels and our analyses indicate that heme interacts with a cytoplasmic regulatory domain to modulate channel activity. We use this information to present a mechanistic framework for heme-dependent regulation across other ion channels.
Results
The KATP family of ion channels respond to intracellular ATP and play a pivotal role in linking cellular metabolism to excitability (7) . The most abundant ventricular KATP channel is a heteroctomeric complex consisting of four pore forming K + channel subunits of the inward rectifier family (Kir6.2) and four regulatory sulphonylurea receptor subunits (SUR2A) which are members of the ABC transporter superfamily (8, 9) , Fig. S1A . The modulation of KATP channel activity is an important process which enhances the cardiac muscle response to oxidative stress (10) .
Heme increases whole-cell KATP currents. The effect of heme on the KATP current from isolated cardiac myocytes was investigated using whole-cell patch-clamp recordings. Cardiac myocytes were held at 0 mV and bath application of the KATP channel opener, P1075 (10 µM), resulted in a whole-cell current which was sensitive to bath application of the selective KATP channel blocker, glibenclamide (10 µM) , that completely blocked the current (Fig. S2A ). The application of heme (500 nM) resulted in an increase in the KATP current, producing a 1.6 fold increase in KATP current (Figs. S2B, C). Heme increased the KATP current in a dose dependent manner with a maximal response achieved with 500 nM heme;
the half maximal increase in KATP channel open probability in response to heme is ~100 nM, Fig. S2C , which is in the physiological range for heme concentration within the cell (11) . Bath application of protoporphyrin IX (Fig. S2F ), Zn-protoporphyrin IX (Fig. S2D, F) or Sn-protoporphyrin IX (Fig. S2F ) did not result in any change in the KATP currents. In further experiments, FeSO4 (500 nM) was superfused onto cardiac myocytes during the recording (Fig. S2E ). However, in contrast to the heme-induced increases in KATP current, application of FeSO4 resulted in a significant decrease in KATP current (Figs.
S2E, F).
We conclude that the increases in current are specific to heme, and are not a consequence of the porphyrin ring or iron alone.
Depletion of intracellular free heme reduces KATP current. The effect of depleting intracellular heme was also tested by incubating myocytes with succinylacetone (SA) which inhibits heme biosynthesis by inhibiting the ALA dehydratase enzyme (the second enzyme in the heme biosynthesis pathway); when intracellular heme levels are decreased a feedback loop causes an increase in expression of aminolevulinate synthase-1 (ALAS-1, the first enzyme in the pathway). After incubation with SA, an increase in the expression of ALAS-1 was observed by Q-PCR (Fig. S3A) . The KATP channels were opened by the channel opener P1075 (10 µM) and the resulting currents were recorded from myocytes in the whole-cell configuration. The currents recorded from the myocytes treated with SA (1 mM) for 4 hours were significantly smaller in amplitude compared to the amplitude of control untreated myocytes (Figs. S3B,C).
Heme increases cardiac KATP single channel activity. KATP channels from ventricular myocytes were recorded in inside-out patches at a holding potential of 70 mV. Immediately after patch excision, the KATP channel open probability (Popen) was high due to lack of ATP in the bath solution (Fig. 1Ai) . The mean amplitude of single channel currents was approximately 4.5 pA with Popen of 0.454 ± 0.063, n = 4 for endogenous KATP channels in cardiac myocytes. A localised perfusion pipette, enabling rapid solution changes to the intracellular side of the patch, delivered a solution containing ATP (500 µM) directly to the excised patch. The addition of ATP to the patch reduced Popen to 0.014 ± 0.009, n = 4
( Fig. 1Aii,B) . Following this, application of hemin (500 nM) with ATP (500 µM) revealed a significant increase in channel activity, Popen to 0.104 ± 0.030, n = 4 ( Fig. 1Aiii,B) .
Identification of the heme binding location. Identification of heme-binding domains within hemedependent ion channels presents a considerable experimental challenge. The KATP subunits Kir6.2 and SUR2A do not contain any CXXCH cytochrome c-like heme binding motifs, as identified in the BK channels (12) . However, SUR2A contains a CXXHX16H motif (nomenclature follows that in (13) The hypothesis that the CXXHX16H motif is involved in heme binding was therefore tested by mutagenesis (residues Cys628, His631, His648).
Inside-out patches from HEK293 cells heterologously expressing wild type Kir6.2 and SUR2A show KATP channel currents with a robust response to heme. In the presence of ATP (500 µM) the KATP channels
had a low open probability (0.023 ± 0.009, n = 9) (Fig. S4B, C) compared to the addition of heme (500 nM) when an increase in open probability is observed (0.109 ± 0.020, n = 9) (Fig. S4B, C) . The increase in open probability was observed over all voltages tested in macropatches (Fig. S4D) . The channels expressed in HEK293 cells were 4.5pA at 70mV and were sensitive to glibenclamide (50µM) which is indicative of the KATP channel currents Fig. S4Aiv ). The effect of mutations in the CXXHX16H motif (at C628S, H631A and H648A) was also tested (Fig. 3) . Single channel analysis revealed that both single mutations C628S and H648A had a substantial effect on the KATP channel response to heme (Fig. 3A, B), whereas the H631A mutation had a minor effect on the heme response (Fig. 3C ). Double and triple mutations showed that any combination of mutations that contained C628S and H648A affected the heme-dependent increases in KATP channel open probability (Fig. 3C ). These data are consistent with the SUR2A subunit of KATP channel being the site of heme binding, and suggest a role for C628 and H648.
Heme binding to SUR2A. In order to further quantify the interaction of heme with the SUR2A subunit, we examined heme binding to two model peptides as well as to a fragment of the SUR2A subunit (residues S615-L933) containing the entire CXXHX16H region. In assessing the spectroscopic properties of these heme-bound species, it is important to note that the spectra for regulatory heme proteins often differ from those of well-known heme proteins such as the globins and cytochrome c, most likely because the heme binds more weakly, and in different orientations.
Peptide A (LPFESCKKHTGVQSKPINRKQPGRYHLDNYE) contains the residues corresponding to C628/H648. At 1:1 hemin:peptide ratio, peptide A binds heme to form a complex that is clearly red- shows a peak at 413 nm; a similar peak of lower intensity was observed in the absorption spectrum of the H648A mutant. As mentioned above, similar absorption patterns have been reported for heme binding to proteins with Cys/His coordination (Table S1 ), typical for low-spin type-2 heme thiolate Fe(III) Soret bands (15) . Overall, these data are consistent with heme binding to the SUR2A subunit of the KATP channel, and are in agreement with the electrophysiology data.
Resonance Raman experiments were used to provide further insight on the SUR2A-hemin interaction.
In the high-frequency, the spectrum of free hemin displays the distinctive features of a ferric 5-coordinate high-spin complex (5c-HS) with characteristic bands at 1370 cm -1 (v4), 1490 cm -1 (v3) and 1571 cm -1 (v2) (Fig. 4Ci , Table S2 ). Table S2 ). The spectroscopic data indicate that hemin binding to the channel occurs rapidly, but that complete formation of low-spin heme is slower and presumably involves a conformational rearrangement that 'locks' the heme into place complex. The H648A mutation (Fig. 4Civ) leads to a significant decrease of the 6c-LS species compared to the wild type protein (Fig. 4Cii) as indicated by the decrease of the intensity of the bands at 1506 cm -1 (v3), at 1590 cm -1 (v2) and 1641 cm -1 (v10). These data are consistent with a decreased intensity of the Soret absorbance band at 413nm for the H648A-hemin complex, and with the electrophysiology data.
Together, the data suggest that heme binds to SUR2A(S615-L933) at a specific location and that H648 plays a significant role. 
Discussion
Most of what is known about the role of heme iron in biology has emerged over many decades from structure/function studies on well-known heme proteins, for example the globins, the cytochromes, and the many and varied catalytic heme enzymes. But there is evidence in the literature that heme acts as a signalling molecule and also regulates a variety of other complex biological events in the cell, which extends the role of heme far beyond the limits of current understanding. As well as roles in control of ion channel function, there is very good evidence for the involvement of heme in circadian control (day/night cycle), in control of transcriptional events and gene expression, and in regulation of phosphorylation and kinase activity (see (1, 3, 17, 18 ) for reviews).
The mechanisms of heme-dependent regulation are very unclear. It is not yet known how heme is stored and mobilized within the cell for regulatory control: heme is insoluble in aqueous solutions, and is most likely bound (weakly) to as yet unknown chaperone/transporter proteins, but the mechanisms of heme transport across the membrane are not established in detail. Heme concentrations in the cell have not been measured precisely (estimates are in the range 100 nM or less (4, 11, 19) , and probably increase during hypoxia and after thrombosis/stroke (20) (21) (22) so that local changes in heme concentration in the cell cannot, at present, be reliably quantified.
Heme binding interactions in ion channels. In the case of ion channel regulation, it has recently
emerged that there is a role for heme (12, (23) (24) (25) (26) , but the observations are largely empirical, so that the molecular basis for the regulatory control within individual channel proteins has yet to be properly defined. A number of heme responsive motifs (27) have been suggested to be involved: these include Cys/Pro (CP) motifs using thiolate ligation to the heme as in the P450s, or Cys/His motifs (3, 14) . In the case of the Slo1 channels (12), a cytochrome c-like CXXCH motif has been implicated (12, 28) . But this raises immediate questions that do not chime with established patterns of behavior in other heme proteins, This is because most proteins bind heme reversibly (i.e. non-covalently), whereas cytochrome c uses complex and specialized biosynthetic machinery to bind heme irreversibly (i.e.
covalently) through thioether bonds from the Cys residues of the CXXCH motif to the heme vinyl groups (29, 30). There is as yet no evidence that ion channels proteins use similarly specialised biosynthetic machinery; thus, it seems unlikely that the heme is covalently attached. Neither the epithelial sodium channels (24) nor the A-type K + channels (23) contain a CXXCH motif, which we interpret to mean that the mode of heme binding is most likely not the same across all ion channels.
In this paper, we have quantified the effect of heme on ATP-dependent potassium channels. These channels couple electrical activity at the membrane to energy metabolism in numerous cells, such as pancreatic cells and cardiac myocytes, and in this way regulate a number of key physiological processes including secretion and muscle contraction. We showed that heme at physiological concentrations is a robust activator of KATP channels, Figs S1, 2. We identified a CXXHX16H heme binding motif on the SUR2A domain as a potential heme binding location. Quantitative analyses of heme binding to model peptides as well as to a fragment of the SUR2A subunit expressed in E. coli demonstrate that heme binds to SUR2A(S615-L933), specifically, at this location. At least as far as the isolated SUR2A domain is concerned (i.e. not within the channel), formation of a low-spin heme species is not instantaneous, and probably occurs after initial formation of a more loosely associated, non-specific heme-protein complex, by a slow conformational transition which "locks" the low-spin SUR2A-hemin complex in place. Mutagenesis, together with single channel data, implicate Cys628 and The CXXHX16H motif (residues 628-648) is located between the first transmembrane domain and the first nucleotide binding domain, Fig. S1 . Sequence alignment of the twelve human c-subfamily ABC proteins ( Fig. S1B) illustrates that the CXXHX16H motif is part of an insertion that is present only in SUR2A and SUR1. SUR1 is the closest homologue to SUR2A (67% identity) within the ABC subfamily c.
However, although SUR1 also has the insertion, the CXXHX16H motif is not conserved between SUR2A
and SUR1. Hence, this particular mode of heme binding is specific to SUR2A, and does not occur in other members of this family of ABC transporters. There is evidence for heme binding to ABCtransporter proteins (31-35) in other (unrelated) heme transport systems, but the heme binding sites are not established.
Looking at all the heme-dependent ion channels identified so far, we note that cysteine is implicated as important for heme binding in all cases (Table S1 ). There is, as yet, no structural information on how heme binds to any ion channel protein. Modelling of SUR2A based on the crystal structure (36) of the homologue MRP1 from C. elegans illustrates the orientation of the two transmembrane and two nucleotide binding domains, Fig. 2 . The region containing the CXXHX16H motif cannot be modelled meaningfully (and might be conformationally mobile) because this insertion is missing in MRP1 C.
elegans, but the model indicates that the heme binding region is close to the first nucleotide binding domain (NBD1, Fig. 2A, B) . In this regard, there are similarities to the structure of human Slo1, because the proposed CXXCH heme binding motif in Slo1 is either invisible or only partly visible in crystal structures (37-39), and is thus assumed to be located in an unstructured (conformationally mobile)
region of the molecule.
Consideration of heme-dependent regulatory mechanisms across other ion channels.
To begin to create a framework for the development of ideas on the mechanisms of heme-dependent ion channel regulation, we have summarised schematically the information that has emerged so far for KATP channels (this work) as well as for Slo1 (BK) (12) and Kv1.4 (23) channels (Scheme 1). In all three channels, we note that the heme interacts with a cytoplasmic domain to modulate channel activity, and in each case the heme is suggested to bind to a flexible region of protein structure. Thus, for the KATP channels, heme binds to the CXXHX16H motif in the cytoplasmic domain of SUR2A; for the Slo1 
Materials and Methods
Detailed methods on the following subjects are available in S1 Appendix, SI Materials and Methods:
isolation of cardiac myocytes, transfection and cell culture, electrophysiology, RNA extraction and quantitative real-time PCR analysis, expression and purification of SUR2A NBD1, peptide synthesis, spectroscopy of heme-bound species, bioinformatics analyses, chemicals and reagents, Table S1 , The grey (TMD0), dark green (TMD1) and light green (TMD2) rectangles represent the transmembrane domains of the sulphonylurea receptor SUR2A in the KATP channel (colour scheme as in Figure 3) Prior to recording, a population of the ventricular myocytes were treated with 1 mM succinylacetone (SA) to inhibit heme synthesis and a population of myocytes were treated with hemin (500 nM) in the presence of bovine serum albumin (BSA) in a 1:1 molar ratio as described before (44) . Baseline correction was performed using GRAMS 32 (Galactic Industries, Salem, NH).
iii.EPR Spectroscopy X-Band (9.4 GHz) EPR spectra were recorded on a Bruker ELEXSYS 500 spectrometer equipped with a standard TE cavity (Bruker) and an Oxford Instruments continuous flow liquid helium cryostat interfaced with a temperature control system. Samples (100 μl) of ferric SUR2A(S615-L933) and site-directed mutants were prepared in 50 mM Hepes, 50 mM NaCl pH 7.5 at a concentration of 100 uM, and transferred to quartz EPR tubes. HHPred target-template sequence alignment was adjusted for consistency with the 4F4C structure and used as input for model generation in Modeller 9v4. 50 models were generated and ranked by the DOPE score, and the best ranking model was used for structure analysis and visualisation in pymol. The SUR2A rat sequence was added for comparison. Representative whole-cell trace of normalised KATP current (pA/pF) in response to P1075 (10 μM) compared to (ii) a current recording from a myocytes pre-treated with SA (1 mM) for 4 hours. C) Mean peak current elicited by P1075 for control myocytes and those incubated in SA for 4 hours illustrated a significant decrease from 21.8 ± 2.5, n = 28 to 10.7 ± 1.8, n = 8
Bioinformatics
(unpaired t-test *P < 0.05). 
